MeiraGTx Holdings plc (MGTX) financial statements (2021 and earlier)

Company profile

Business Address 450 EAST 29TH STREET
NEW YORK, NY 10016
State of Incorp.
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments21022768
Cash and cash equivalents21022768
Receivables3823 
Prepaid expense742
Other current assets525
Other undisclosed current assets1312 
Total current assets:27326975
Noncurrent Assets
Finance lease, right-of-use asset227
Operating lease, right-of-use asset2122
Property, plant and equipment442422
Intangible assets, net (including goodwill)2  
Intangible assets, net (excluding goodwill)2  
Other noncurrent assets00 
Other undisclosed noncurrent assets220
Total noncurrent assets:915522
TOTAL ASSETS:36432497
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities282215
Accounts payable743
Accrued liabilities211812
Debt320
Other liabilities0 0
Other undisclosed current liabilities2426 
Total current liabilities:544915
Noncurrent Liabilities
Long-term debt and lease obligation20220
Capital lease obligations0
Operating lease, liability2022
Liabilities, other than long-term debt000
Deferred rent credit  0
Deferred income tax liabilities00
Other undisclosed noncurrent liabilities51620
Total noncurrent liabilities:71840
Total liabilities:12513316
Stockholders' equity
Stockholders' equity attributable to parent23919181
Common stock000
Additional paid in capital504396229
Accumulated other comprehensive income (loss)(5)(2)0
Accumulated deficit(261)(203)(148)
Total stockholders' equity:23919181
TOTAL LIABILITIES AND EQUITY:36432497

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Gross profit:1613 
Operating expenses(78)(72)(78)
Operating loss:(63)(58)(78)
Nonoperating income (expense)54(4)
Investment income, nonoperating100
Foreign currency transaction gain (loss), before tax33(4)
Interest and debt expense(0)(0)(0)
Loss from continuing operations before equity method investments, income taxes:(58)(55)(82)
Other undisclosed loss from continuing operations before income taxes  (2)
Loss from continuing operations before income taxes:(58)(55)(83)
Income tax benefit16100
Loss before gain (loss) on sale of properties:(42)(45)(83)
Other undisclosed net loss(16)(10) 
Net loss attributable to parent:(58)(55)(83)
Preferred stock dividends and other adjustments  (2)
Net loss available to common stockholders, diluted:(58)(55)(85)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net loss:(58)(55)(83)
Other comprehensive loss  (0)
Comprehensive loss:(58)(55)(83)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(3)(2)3
Comprehensive loss, net of tax, attributable to parent:(61)(57)(81)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: